Mannan from Aloe saponaria inhibits tumoral cell activation and proliferation

International Immunopharmacology

Volumn 4, Issue 3, 2004, Pages 411-418

  Sampedro, M Cecilia ^a   Artola, Rodolfo L ^b   Murature, Mariano ^c   Murature, Domingo ^b   Ditamo, Yanina ^a   Roth, German A ^a   Kivatinitz, Silvia ^a  

^a Centro de Investigaciones En Quimica Biologica de Cordoba   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c Coop Agropecuaria Productores Y C ^*  (Argentina)

Author keywords

Activation; Aloe saponaria; Mannan; Tumoral cell

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 2 RECEPTOR; MANNAN;

ALOE; ALOE SAPONARIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; MALE; MEDICINAL PLANT; MITOSIS INHIBITION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ALOE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CRICETINAE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MANNANS; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; PLANT LEAVES; SPLEEN;

EID: 1642268364     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.12.016     Document Type: Article

References (26)

1. McAnalley BH. Process for preparation of aloe products. United States Patent 4,957,907; September 18, 1990.
2. Robson M.C., Heggers J.P., Hagstrom W.J. Myth, magic, witchcraft or fact? Aloe vera revisited. J. Biol. Chem. 3:1982;157-163.
3. Reynolds T., Dweck A.A. Aloe vera gel leaf: a review update. J. Ethnopharmacol. 68:1999;3-37.
4. Wooles W.R., Di Luzio N.R. Reticuloendothelial function and the immune response. Science. 142:1963;1078.
5. Pospisil M., Jary J., Netikova J., Marek M. Glucan-induced enhancement of hemopoietic recovery in gamma-irradiated mice. Experientia. 38:1982;1232-1234.
6. Burgaleta C., Golde D.W. Effect of glucan on granulopoiesis and macrophage genesis in mice. Cancer Res. 37:1997;1739.
7. Maisin J.r., Kondi-Tamba A., Mattelin G. Polysaccharides induce radioprotection of murine hemopoietic stem cells and increase the LD50/30 days. Radiat. Res. 105:1996;276-281.
8. Harris C., Pierce K., King G., Yates K.M., Hall J., Tizard I. Efficacy of acemannan in treatment of canine and feline spontaneous neoplasm. Mol. Biother. 3:1991;207-213.
9. Peng S.Y., Norma L.J., Curtin J., Corrier D., McDaniel H.R., Busbee D. Decreased mortality of normal murine sarcoma in mice treated with the inmunomodulador accemannan. Mol. Biother. 3:1991;79-87.
10. King G.K., Yates K.M., Greenlee P.G.et al. The effects of acemannan immunostimulant in combination with surgery and radiationtherapy on spontaneous canine and feline fibrosarcomas. J. Am. Hosp. Assoc. 31:1995;439-447. [es igual a la 12].
11. Corsi M.M., Bertelli A.A., Gaja G., Fulgenzi A., Ferrero M.E. The therapeutic potential of Aloe vera in tumor-bearing rats. Int. J. Tissue React. 20:1998;115-118.
12. King G.K., Yates K.M., Greenlee P.G.et al. The effect of acemannan immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas. J. Am. Anim. Hosp. Assoc. 31:1995;439-447.
13. Winters W.D., Benavides R., Clouse W.J. Effects of aloe extracts on human normal and tumor cells in vitro. Econ. Bot. 35:1981;89-95.
14. Wajner M., Santos K.D., Schlottfeldt J.L., Rocha M.P., Wannmacher C.M.D. Inhibition of mitogen-activated proliferation of human peripheral lymphocytes in vitro by propionic acid. Clin. Sci. 96:1999;99-103.
15. Sampedro M.C., Motrán C., Gruppi A., Kivatinitz S.C. VLDL modulates the cytokine secretion profile to a proinflammatory pattern. Biochem. Biophys. Res. Commun. 285:2001;393-399.
16. Benini S., Manara M.C., Baldini N.et al. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewin's sarcoma cells. Clin. Cancer Res. 7:2001;1790-1797.
17. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 73:1993;5-8.
18. Waldmann T.A. The interleukin-2 receptor. J. Biol. Chem. 266:1994;2681-2684.
19. Minami Y.T., Kono T., Miyazaki T., Taniguchi T. The IL-2 receptor complex: its structure, function and target genes. Annu. Rev. Immunol. 11:1993;245-268.
20. Nakari T.M., Robertson M.et al. Interleukin 2 receptor γ chain expression on resting and activated lymphoid cells. J. Exp. Med. 180:1994;241-251.
21. Karaca K., Sharma J.M., Nordgren R. Nitric oxide production by chicken macrophages activated by acemannan, a complex carbohydrate extracted from Aloe vera. Int. J. Immunopharmacol. 17:1995;183-188.
22. de Maagd R.A., MacKenzie W.A., Schuurman H.J., Ritter M.A., Price K.M., Broekhuizen R.et al. The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies. Immunology. 54:1985;745-754.
23. Larche M., Lamb J.R., O'Hehir R.E., Imami-Shita N., Zanders E.D., Quint D.E.et al. Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor. Immunology. 65:1988;617-622.
24. Larche M., Lamb J.R., Ritter M.A. A novel T-lymphocyte molecule that may function in the induction of self-tolerance and MHC-restriction within the human thymic microenvironment. Immunology. 64:1988;101-105.
25. Larche M., Lamb J.R., Ritter M.A. p145-MR6: a novel T cell surface molecule with a role in tolerance to self. Adv. Exp. Med. Biol. 237:1988;413-417.
26. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.